Literature DB >> 29157126

Sample size calculations for blinding assessment.

Victoria Landsman1,2, Mark Fillery3, Howard Vernon3, Heejung Bang4.   

Abstract

Blinding is a critical component in randomized clinical trials along with treatment effect estimation and comparisons between the treatments. Various methods have been proposed for the statistical analyses of blinding-related data, but there is little guidance for determining the sample size for this type of data, especially if blinding assessment is done in pilot studies. In this paper, we try to fill this gap and provide simple methods to address sample size calculations for a "new" study with different research questions and scenarios. The proposed methods are framed in terms of estimation/precision or statistical testing to allow investigators to choose the best suited method for their goals. We illustrate the methods using worked examples with real data.

Entities:  

Keywords:  Blinding index; clinical trial; contingency table; masking; patient blinding

Mesh:

Year:  2017        PMID: 29157126      PMCID: PMC5960641          DOI: 10.1080/10543406.2017.1399898

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  31 in total

1.  A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials.

Authors:  Erin Mathieu; Robert D Herbert; Kevin McGeechan; Jemma J Herbert; Alexandra L Barratt
Journal:  J Clin Epidemiol       Date:  2014-06       Impact factor: 6.437

2.  Blinding in pharmaceutical clinical trials: An overview of points to consider.

Authors:  Adam Crisp
Journal:  Contemp Clin Trials       Date:  2015-06-02       Impact factor: 2.226

3.  Blinding in clinical trials: a practical approach.

Authors:  Heejung Bang; Jongbae J Park
Journal:  J Altern Complement Med       Date:  2012-11-09       Impact factor: 2.579

4.  Acupuncture for subacute stroke rehabilitation: a Sham-controlled, subject- and assessor-blind, randomized trial.

Authors:  Jongbae Park; Adrian R White; Martin A James; Anthony G Hemsley; Paul Johnson; John Chambers; Edzard Ernst
Journal:  Arch Intern Med       Date:  2005-09-26

Review 5.  Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010.

Authors:  Christopher Baethge; Oliver P Assall; Ross J Baldessarini
Journal:  Psychother Psychosom       Date:  2013-03-21       Impact factor: 17.659

6.  Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.

Authors:  Adrielle H Houweling; Stan Shapiro; Jacqueline M Cohen; Susan R Kahn
Journal:  Clin Trials       Date:  2014-06-05       Impact factor: 2.486

7.  Investigational Vertebroplasty Efficacy and Safety Trial: detailed analysis of blinding efficacy.

Authors:  Waleed Brinjikji; Bryan A Comstock; Patrick J Heagerty; Jeffrey G Jarvik; David F Kallmes
Journal:  Radiology       Date:  2010-10       Impact factor: 11.105

8.  A new framework for interpreting the outcomes of imperfectly blinded controlled clinical trials.

Authors:  Ognjen Arandjelović
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

Review 9.  Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.

Authors:  Isabelle Boutron; Lydia Guittet; Candice Estellat; David Moher; Asbjørn Hróbjartsson; Philippe Ravaud
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

10.  Effectiveness and Safety of Electroacupuncture on Poststroke Urinary Incontinence: Study Protocol of a Pilot Multicentered, Randomized, Parallel, Sham-Controlled Trial.

Authors:  Seungwon Shin; Jiwon Lee; Ami Yu; Junghee Yoo; Euiju Lee
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-30       Impact factor: 2.629

View more
  6 in total

1.  Overdispersion models for correlated multinomial data: Applications to blinding assessment.

Authors:  V Landsman; D Landsman; C S Li; H Bang
Journal:  Stat Med       Date:  2019-08-28       Impact factor: 2.373

2.  Blinding Assessment: One Step Forward.

Authors:  Jeehyoung Kim; Jongbae J Park; Heejung Bang; Jafar Kolahi
Journal:  Dent Hypotheses       Date:  2021-12-21

3.  The Feasibility of Blinding Intraoperative Electro-Auricular Acupuncture Under Neuraxial Anesthesia.

Authors:  Stephanie I Cheng; Ryan M Norman; Danya DeMeo; Haoyan Zhong; Lauren H Turteltaub; Moira M McCarthy; Robert G Marx; Sabrina M Strickland; Anne M Kelly
Journal:  Med Acupunct       Date:  2021-08-17

Review 4.  Applying Lessons Learned From COVID-19 Therapeutic Trials to Improve Future ALI/ARDS Trials.

Authors:  Qun Wu; Meghan E Pennini; Julie N Bergmann; Marina L Kozak; Kristen Herring; Kimberly L Sciarretta; Kimberly L Armstrong
Journal:  Open Forum Infect Dis       Date:  2022-07-30       Impact factor: 4.423

5.  The iSTOPP study: Protocol for a proof-of-concept randomised clinical trial of sensory discrimination training in people with persistent neck pain.

Authors:  Daniel S Harvie; Nick Olthof; Andrea Hams; Hayley Thomson; Michel W Coppieters
Journal:  Contemp Clin Trials Commun       Date:  2021-07-14

Review 6.  Placebo and Side Effects Confound Clinical Trials on New Antitussives.

Authors:  Ronald Eccles
Journal:  Lung       Date:  2021-07-19       Impact factor: 2.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.